To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
NCT00709085 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320
Last updated 2009-11-25
Summary
The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis and hepatocellular carcinoma. It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of liver cirrhosis and hepatocellular carcinoma.
Conditions
Sponsors & Collaborators
-
National Science and Technology Council, Taiwan
collaborator OTHER_GOV -
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Ming-Fu Chang, Ph.D. · National Taiwan University College of Medicine
Eligibility
- Min Age
- 50 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
To Study the Effects of Host Genetic Factors on Liver Cirrhosis
NCT05095181 ·Status: COMPLETED
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
NCT03804593 ·Status: COMPLETED
-
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT06550739 ·Status: COMPLETED
-
Hepatobiliary Tumors Tissue Samples Acquisition
NCT04445532 ·Status: UNKNOWN
-
Prognostic Models for HCC Based on Tumor Micronecrosis
NCT05837065 ·Status: UNKNOWN
-
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
NCT04076631 ·Status: UNKNOWN
-
Epidemiologic Study of Hepatocellular Carcinoma in the US
NCT02358070 ·Status: COMPLETED
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
ctDNA Monitoring in Patients With HCC and mCRC
NCT07001085 ·Status: RECRUITING ·Phase: NA
-
Pangenomic Study During Alcoholic Cirrhosis
NCT01065233 ·Status: COMPLETED
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma
NCT07265271 ·Status: RECRUITING
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Biochemical and Genetic Markers in Liver Diseases
NCT01706614 ·Status: UNKNOWN
-
Proteomic Analysis of Human Hepatocellular Carcinoma
NCT01177631 ·Status: COMPLETED ·Phase: NA
-
Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients
NCT02587793 ·Status: COMPLETED
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
NCT06778317 ·Status: NOT_YET_RECRUITING
-
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
NCT03722628 ·Status: UNKNOWN
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING